Skip to main content

Revvity statistics

  • RVTY · NYSE
  • Instruments
  • Health Care Equipment
  • S&P 500
$154.39−1.67%Close 13 Nov 2026

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Enterprise value$19.41B
EV / EBITDA24.71
EV / sales6.60

Share price

Latest close$154.39
Day's change−1.7%
52-week high$171.74
52-week low$81.22
From 52-week high−10.1%
Return · 1 month+1.1%
Return · 3 months+24.4%
Return · year to date+59.6%
Return · 1 year+64.0%
Beta · 1 year against the S&P 5001.15
50-day average$150.40
200-day average$114.03
RSI 1448.9
Average volume · 20 sessions1.8M

Margins and returns

For fiscal 2025, as filed.

Gross margin54.8%
Operating margin12.5%
Net margin8.4%
Free cash flow margin17.8%
Return on equity3.2%
Return on assets2.6%
Return on invested capital3.0%
Return on capital employed3.2%
Stock-based compensation / revenue0.8%

Financial position

At the end of fiscal 2025.

Cash and equivalents$919.9M
Total debt$3.42B
Net debt$2.50B
Current ratio1.68
Debt / equity0.47
Net debt / EBITDA3.28
Interest coverage3.87

Shares and dividends

For fiscal 2025, as filed.

Diluted shares117M
Net share repurchases$817.9M
Dividends per share$0.28
Dividend payout13.6%

Taxes

For fiscal 2025, as filed.

Income tax expense$28.39M
Effective tax rate10.6%

RVTY in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.